Related Experiment Video
Updated: Apr 3, 2026

09:47
Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
Published on: December 15, 2023
2.0K
Identification of Conversion from Normal Elderly Cognition to Alzheimer's Disease using Multimodal Support Vector
Ye Zhan1, Kewei Chen2, Xia Wu1,3
1College of Information Science and Technology, Beijing Normal University, Beijing, China.
Journal of Alzheimer'S Disease : JAD
|September 25, 2015
Summary
Early detection of Alzheimer's disease (AD) is crucial. This study uses multimodal imaging and machine learning to identify normal elderly individuals at risk of converting to mild cognitive impairment or AD.
Area of Science:
- Neuroscience
- Medical Imaging
- Machine Learning
Background:
- Alzheimer's disease (AD) is a progressive neurodegenerative disorder affecting the elderly.
- Early identification of conversion from normal cognition to mild cognitive impairment (MCI) or AD is critical for timely intervention.
- Current diagnostic methods may not capture subtle early changes effectively.
Purpose of the Study:
- To develop and validate a multimodal machine learning model for early detection of cognitive decline.
- To differentiate between normal elderly controls (NC) who convert to MCI/AD and those who do not.
- To assess the efficacy of combining magnetic resonance imaging (MRI) and positron emission tomography (PET) data.
Main Methods:
- Utilized a multimodal support vector machine (SVM) approach.
- Employed data from two independent cohorts (training and testing sets) from the Alzheimer's Disease Neuroimaging Initiative (ADNI) database.
- Included MRI and PET imaging data from 121 AD patients, 120 NC, 20 NC converters, and 20 NC non-converters.
Main Results:
- Multimodal classification achieved 67.5% accuracy, 73.33% sensitivity, and 64% specificity in distinguishing NC converters from non-converters.
- Feature selection improved classification performance to 70% accuracy, 75% sensitivity, and 66.67% specificity.
- Multimodal data significantly outperformed single-modality approaches for predicting NC to MCI/AD conversion.
Conclusions:
- A multimodal SVM model effectively identifies elderly individuals at risk of developing MCI or AD.
- Combining MRI and PET imaging enhances the accuracy of early cognitive decline detection.
- This approach holds promise for improving clinical diagnosis and guiding pathological research in Alzheimer's disease.
Related Concept Videos
Alzheimer's Disease: Overview
2.0K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
2.0K
Alzheimer's Disease: Treatment
1.2K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.2K

